PMC:7463108 / 59040-59258
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T578 | 145-153 | Body_part | denotes | striatum | http://purl.org/sig/ont/fma/fma77618 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T130 | 145-153 | Body_part | denotes | striatum | http://purl.obolibrary.org/obo/UBERON_0002435 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T21571 | 30-38 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
| T2284 | 75-87 | Chemical | denotes | dolutegravir | http://purl.obolibrary.org/obo/CHEBI_76010 |
| T19714 | 96-104 | Chemical | denotes | abacavir | http://purl.obolibrary.org/obo/CHEBI_421707 |
| T29469 | 118-128 | Chemical | denotes | lamivudine | http://purl.obolibrary.org/obo/CHEBI_63577 |
| T20462 | 208-216 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2051 | 16-19 | Gene | denotes | Tat | Gene:234724 |
| 2078 | 30-38 | Chemical | denotes | morphine | MESH:D009020 |
| 2079 | 75-87 | Chemical | denotes | dolutegravir | MESH:C562325 |
| 2080 | 96-104 | Chemical | denotes | abacavir | MESH:C106538 |
| 2081 | 118-128 | Chemical | denotes | lamivudine | MESH:D019259 |
| 2082 | 208-216 | Chemical | denotes | morphine | MESH:D009020 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T804 | 0-218 | Sentence | denotes | Irrespective of Tat exposure, morphine significantly reduced the levels of dolutegravir (f) and abacavir (g), but not lamivudine (h), within the striatum, as compared to placebo. (* p < 0.05; main effect for morphine). |